(4R)-3-[(3S,5R)-5-(2,4-difluorophenyl)-5-methyloxolane-3-carbonyl]-4-phenyl-1,3-oxazolidin-2-one
C21H19F2NO4 — CID 134383662
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R)-3-[(3S,5R)-5-(2,4-difluorophenyl)-5-methyloxolane-3-carbonyl]-4-phenyl-1,3-oxazolidin-2-one
(4R)-3-[(3S,5R)-5-(2,4-difluorophenyl)-5-methyloxolane-3-carbonyl]-4-phenyl-1,3-oxazolidin-2-one (PubChem CID 134383662) has the molecular formula C21H19F2NO4 and a molecular weight of 387.38 g/mol. Its IUPAC name is (4R)-3-[(3S,5R)-5-(2,4-difluorophenyl)-5-methyloxolane-3-carbonyl]-4-phenyl-1,3-oxazolidin-2-one.
Molecular Properties
| Compound Name | (4R)-3-[(3S,5R)-5-(2,4-difluorophenyl)-5-methyloxolane-3-carbonyl]-4-phenyl-1,3-oxazolidin-2-one |
|---|---|
| PubChem CID | 134383662 |
| Molecular Formula | C21H19F2NO4 |
| Molecular Weight | 387.38 g/mol |
| Exact Mass | 387.13 |
| IUPAC Name | (4R)-3-[(3S,5R)-5-(2,4-difluorophenyl)-5-methyloxolane-3-carbonyl]-4-phenyl-1,3-oxazolidin-2-one |
| SMILES | C[C@]1(c2ccc(F)cc2F)C[C@H](C(=O)N2C(=O)OC[C@H]2c2ccccc2)CO1 |
| InChI | InChI=1S/C21H19F2NO4/c1-21(16-8-7-15(22)9-17(16)23)10-14(11-28-21)19(25)24-18(12-27-20(24)26)13-5-3-2-4-6-13/h2-9,14,18H,10-12H2,1H3/t14-,18-,21+/m0/s1 |
| InChIKey | CBCWHTJMTSELER-DHUIEDIVSA-N |
| XLogP | 3.94 |
| TPSA | 55.84 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 387.38 |
| LogP ≤ 5 | 3.94 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134383662 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.